Nick Williams
Partner
Corporate
Corporate Partner Nick Williams provides corporate and commercial advice to UK and international public and private companies and financial advisory firms. His expertise includes mergers and acquisitions, public takeovers, corporate finance, flotations (Official List/LSE Main Market, AIM and AQSE Growth Market), fundraisings on and off market, joint ventures, corporate governance and funds. His expertise spans a range of sectors, including, in particular, financial services, real estate, healthcare, retail, renewables and natural resources. Much of his work involves international businesses.
Work highlights
INVESTMENT
Advising Jiangxi Copper (Hong Kong) Investment Company Limited in relation to its US$31,000,000 investment in SolGold plc, the London and TSX-listed resources company.
STOCK EXCHANGE LISTING
Acting for Aura Renewable Acquisitions Plc on its admission to the Standard Segment of the Financial Conduct Authority’s Official List and the London Stock Exchange’s Main Market.
INVESTMENT
Advising an investor on its c. US$265,000,000 investment in an offshore fund and subsequent restructuring of the fund structure.
CORPORATE ADVISORY
Acting for Dowgate Capital Limited in its role as corporate adviser and broker to Otaq plc (OTAQ) on a £3.6m fundraising and the admission of OTAQ’s ordinary shares to trading on the Access Segment of the AQSE Growth Market.
SALE
Acting for a shareholder in relation to the sale of a company which owned and operated a Formula 1 racing team.
AIM IPOs
Advising numerous businesses on their AIM IPOs, including Kada Technology Holdings Limited, Financial Payment Systems Limited, Cosmedia Group Holdings Limited, Jetion Holdings Limited, China Medical System Holdings Limited, Green & Smart Holdings plc, Pan Pacific Aggregates plc, Yangtze China Investment Limited and Rare Earths Global Limited.
SPINOUT AND FINANCING
Advising Greenlane Renewables Inc., a TSX listed Canadian company on the English law aspects of its spinout from Pressure Technologies plc and concurrent $8.4m financing.
fundraising
Advising the underwriters on the English law/AIM Rules aspects of an initial public offering by GW Pharmaceuticals plc of American Depository Shares (“ADSs”) on the NASDAQ Global Market to raise $32.7m and a follow on offering by GW Pharmaceuticals plc of ADSs on NASDAQ to raise $101.1m.
overseas sale
Advising the shareholders of a logistics company on its sale to an overseas buyer.
CONVERTIBLE BONDS
Advising WH Ireland Limited as joint broker to Defenx plc in relation to an offer of convertible bonds and shares raising gross proceeds of £2.99m.
FUNDRAISING
Advising Optiva Securities Limited on its role as broker to Asiamet Resources Limited in a £10m equity fundraising on AIM.
ACQUISITIONS
Advising an IFA business on its acquisitions, structuring and general corporate affairs.
BOND PROGRAMME
Advising Dozens Savings Plc on its £m 5% secured bond programme which was listed on the NEX Exchange Growth Market.
Services
Sectors
Recent articles
Insights
The government updated the exemptions which allow shares and other financial instruments to be marketed to High Net Worth Individuals.
06/03/2024
Insights
The Economic Crime and Corporate Transparency Act 2023 (the “Act”) aims to deliver a range of reforms to tackle economic crime and improve transparency over corporate entities.
06/02/2024
10/01/2024
Insights
DMH Stallard was legal adviser to Chill Brands Group plc on the fundraisings and publication of the prospectus and liaised with the Financial Conduct Authority
10/12/2023